Skip to Content
Merck
  • Development of a novel genetically modified bioluminescent-bacteria-based assay for detection of fluoroquinolones in animal-derived foods.

Development of a novel genetically modified bioluminescent-bacteria-based assay for detection of fluoroquinolones in animal-derived foods.

Analytical and bioanalytical chemistry (2014-10-31)
Guyue Cheng, Xiaobing Dong, Yulian Wang, Dapeng Peng, Xu Wang, Haihong Hao, Shuyu Xie, Wei Qu, Zhenli Liu, Zonghui Yuan
ABSTRACT

Fluoroquinolones (FQNs) are broad-spectrum antibacterial agents widely used in animal husbandry and aquaculture. The residues and antimicrobial resistance of such antibiotics are a major public health concern. To realize multianalyte detection of FQN residues, a genetically modified bacterium, Escherichia coli pK12 harboring plasmid pRecAlux3, was constructed in this study to develop a bioluminescent-bacteria-based assay for the detection of FQNs in animal-derived foods. This assay was based on the principle of induction of an SOS response by FQNs via inducing the recA-promoter-fused luciferase reporter gene existing on the plasmid pRecAlux3. E. coli pK12 was able to recognize 11 FQNs: difloxacin, enrofloxacin, ciprofloxacin, sarafloxacin, norfloxacin, danofloxacin, ofloxacin, pefloxacin, lomefloxacin, marbofloxacin, and orbifloxacin. This method could be applied to 11 edible tissues, including milk, fish muscle, and the muscles, livers, and kidneys of cattle, chickens, and pigs, with a very simple and rapid sample extraction procedure using only phosphate-buffered saline. The limits of detection of the FQNs were between 12.5 and 100 μg kg(-1), all of which were lower than the maximum residue limits. Most of the recoveries of the FQNs were in the range from 60 to 120 %, and the interassay coefficients of variation were less than 30 %. This method, confirmed by high-performance liquid chromatography, is reliable and can be used as both a screening test and a semiquantitative assay, when the identity of a single type of FQN is known.

MATERIALS
Product Number
Brand
Product Description

Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard
Supelco
Marbofloxacin, VETRANAL®, analytical standard
USP
Erythromycin, United States Pharmacopeia (USP) Reference Standard
Supelco
Sulfaquinoxaline, PESTANAL®, analytical standard
Supelco
Sulfamethazine, VETRANAL®, analytical standard
Sigma-Aldrich
Erythromycin standard solution, 1 mg/mL in H2O
Sigma-Aldrich
Erythromycin, tested according to Ph. Eur.
Sigma-Aldrich
Sulfamethazine, 99.0-101.0% (on dried basis)
Sigma-Aldrich
Ampicillin, meets USP testing specifications
Sigma-Aldrich
Erythromycin, meets USP testing specifications
Sigma-Aldrich
Erythromycin, potency: ≥850 μg per mg
USP
Sulfaquinoxaline, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Erythromycin, BioReagent, suitable for cell culture
Supelco
Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material
Enrofloxacin for system suitability, European Pharmacopoeia (EP) Reference Standard
Marbofloxacin, European Pharmacopoeia (EP) Reference Standard
Norfloxacin for system suitability, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Ciprofloxacin, ≥98% (HPLC)
Sigma-Aldrich
Enrofloxacin, ≥99.0%
Supelco
Norfloxacin, analytical standard, ≥98% (TLC)
Sigma-Aldrich
Ofloxacin, fluoroquinolone antibiotic
Sigma-Aldrich
Ampicillin, anhydrous, 96.0-102.0% (anhydrous basis)
Sigma-Aldrich
Oxolinic acid, quinolone antibiotic
USP
Ofloxacin, United States Pharmacopeia (USP) Reference Standard
Supelco
Danofloxacin, VETRANAL®, analytical standard
Enrofloxacin, European Pharmacopoeia (EP) Reference Standard
Ampicillin, anhydrous, European Pharmacopoeia (EP) Reference Standard
Supelco
Enrofloxacin, VETRANAL®, analytical standard
Supelco
Ciprofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Ofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material